127 related articles for article (PubMed ID: 35245522)
1. Paraprobiotic Enterococcus faecalis EC-12 prevents the development of irinotecan-induced intestinal mucositis in mice.
Nobre LMS; da Silva Lopes MH; Geraix J; Cajado AG; Silva JMR; Ribeiro LR; Freire RS; Cavalcante DIM; Wong DVT; Alves APNN; Lima-Júnior RCP
Life Sci; 2022 May; 296():120445. PubMed ID: 35245522
[TBL] [Abstract][Full Text] [Related]
2. Bifidobacterium longum subsp. longum 5
Quintanilha MF; Miranda VC; Souza RO; Gallotti B; Cruz C; Santos EA; Alvarez-Leite JI; Jesus LCL; Azevedo V; Trindade LM; Cardoso VN; Ferreira E; Carvalho BA; Soares PMG; Vieira AT; Nicoli JR; Martins FS
Life Sci; 2022 Jan; 289():120243. PubMed ID: 34922941
[TBL] [Abstract][Full Text] [Related]
3. The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis.
Wong DV; Lima-Júnior RC; Carvalho CB; Borges VF; Wanderley CW; Bem AX; Leite CA; Teixeira MA; Batista GL; Silva RL; Cunha TM; Brito GA; Almeida PR; Cunha FQ; Ribeiro RA
PLoS One; 2015; 10(10):e0139985. PubMed ID: 26440613
[TBL] [Abstract][Full Text] [Related]
4. Paraprobiotic Lacticaseibacillus rhamnosus Protects Intestinal Damage in an Experimental Murine Model of Mucositis.
Trindade LM; Torres L; Matos ID; Miranda VC; de Jesus LCL; Cavalcante G; de Souza Oliveira JJ; Cassali GD; Mancha-Agresti P; de Carvalho Azevedo VA; Maioli TU; Cardoso VN; Martins FDS; de Vasconcelos Generoso S
Probiotics Antimicrob Proteins; 2023 Apr; 15(2):338-350. PubMed ID: 34524605
[TBL] [Abstract][Full Text] [Related]
5. The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan.
Arifa RDN; Paula TP; Madeira MFM; Lima RL; Garcia ZM; Ÿvila TV; Pinho V; Barcelos LS; Pinheiro MVB; Ladeira LO; Krambrock K; Teixeira MM; Souza DG
Pharmacol Res; 2016 May; 107():102-110. PubMed ID: 26987941
[TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice.
Lima-Júnior RC; Freitas HC; Wong DV; Wanderley CW; Nunes LG; Leite LL; Miranda SP; Souza MH; Brito GA; Magalhães PJ; Teixeira MM; Cunha FQ; Ribeiro RA
Br J Pharmacol; 2014 May; 171(9):2335-50. PubMed ID: 24428790
[TBL] [Abstract][Full Text] [Related]
7. TLR4 deficiency upregulates TLR9 expression and enhances irinotecan-related intestinal mucositis and late-onset diarrhoea.
Wong DVT; Holanda RBF; Cajado AG; Bandeira AM; Pereira JFB; Amorim JO; Torres CS; Ferreira LMM; Lopes MHS; Oliveira RTG; Pereira AF; Sant'Ana RO; Arruda LM; Ribeiro-Júnior HL; Pinheiro RF; Almeida PRC; Carvalho RF; Chaves FF; Rocha-Filho DR; Cunha FQ; Lima-Júnior RCP
Br J Pharmacol; 2021 Oct; 178(20):4193-4209. PubMed ID: 34216140
[TBL] [Abstract][Full Text] [Related]
8. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
Soares PM; Lima-Junior RC; Mota JM; Justino PF; Brito GA; Ribeiro RA; Cunha FQ; Souza MH
Cancer Chemother Pharmacol; 2011 Sep; 68(3):713-20. PubMed ID: 21153821
[TBL] [Abstract][Full Text] [Related]
9. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
[TBL] [Abstract][Full Text] [Related]
10. Role of regulatory T cells in irinotecan-induced intestinal mucositis.
Fernandes C; Wanderley CWS; Silva CMS; Muniz HA; Teixeira MA; Souza NRP; Cândido AGF; Falcão RB; Souza MHLP; Almeida PRC; Câmara LMC; Lima-Júnior RCP
Eur J Pharm Sci; 2018 Mar; 115():158-166. PubMed ID: 29307857
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.
Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC
Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial DNA as a Possible Ligand for TLR9 in Irinotecan-induced Small Intestinal Mucositis.
Ávila TV; Menezes-Garcia Z; do Nascimento Arifa RD; Soriani FM; Machado AMV; Teixeira MM; Fagundes CT; Souza DG
Immunol Invest; 2022 Aug; 51(6):1756-1771. PubMed ID: 35152824
[TBL] [Abstract][Full Text] [Related]
13. Preventative effects of selenium-enriched
Qiu Y; Zhang J; Ji R; Zhou Y; Shao L; Chen D; Tan J
Benef Microbes; 2019 May; 10(5):569-577. PubMed ID: 30964326
[TBL] [Abstract][Full Text] [Related]
14. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats.
Tang Y; Wu Y; Huang Z; Dong W; Deng Y; Wang F; Li M; Yuan J
Nutrition; 2017 Jan; 33():96-104. PubMed ID: 27427511
[TBL] [Abstract][Full Text] [Related]
15. Luteolin prevents irinotecan-induced intestinal mucositis in mice through antioxidant and anti-inflammatory properties.
Boeing T; de Souza P; Speca S; Somensi LB; Mariano LNB; Cury BJ; Ferreira Dos Anjos M; Quintão NLM; Dubuqoy L; Desreumax P; da Silva LM; de Andrade SF
Br J Pharmacol; 2020 May; 177(10):2393-2408. PubMed ID: 31976547
[TBL] [Abstract][Full Text] [Related]
16. Administration of a Probiotic Mixture Ameliorates Cisplatin-Induced Mucositis and Pica by Regulating 5-HT in Rats.
Wu Y; Wu J; Lin Z; Wang Q; Li Y; Wang A; Shan X; Liu J
J Immunol Res; 2021; 2021():9321196. PubMed ID: 34568500
[TBL] [Abstract][Full Text] [Related]
17. Dihydrotanshinone attenuates chemotherapy-induced intestinal mucositis and alters fecal microbiota in mice.
Wang L; Wang R; Wei GY; Wang SM; Du GH
Biomed Pharmacother; 2020 Aug; 128():110262. PubMed ID: 32447214
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model.
Yeung CY; Chan WT; Jiang CB; Cheng ML; Liu CY; Chang SW; Chiang Chiau JS; Lee HC
PLoS One; 2015; 10(9):e0138746. PubMed ID: 26406888
[TBL] [Abstract][Full Text] [Related]
19. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice.
Hamouda N; Sano T; Oikawa Y; Ozaki T; Shimakawa M; Matsumoto K; Amagase K; Higuchi K; Kato S
Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):159-168. PubMed ID: 28374966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
